Figure 1. New Medications versus R&D Spending in the U.S.

Figure 2. Population Size for the United States and Puerto Rico: July 1, 2003

Figure 3. Median Age of the U.S. Population by State in 2000

Figure 4. The Aging Population of the U.S.

Figure 5. Percent of the U.S. Population Over Age 65 by State in 2000

Figure 6. Median U.S. Household Income by State in 1999

Figure 7. Domestic R&D Spending by Function for 2002

Figure 8. North American Drug Purchases—Retail Pharmacies

Figure 9. Percentage of U.S. Patients Not Receiving Recommended Healthcare

Figure 10. IT Budgets as a Percent of Revenue across Industries

Figure 11. Scenario 1: Customized Therapeutics and Free Market

Figure 12. Scenario 2: Blockbuster and Free Market

Figure 13. Scenario 3: Blockbuster and Price Control

Figure 14. Scenario 4: Customized Therapeutics and Price Control

Table 1. Largest Pharmaceutical Companies by Revenue, U.S. Only, 2003

Table 2. Top Five Biotechnology Companies in 2003, Therapeutic Drug Sales Only

Table 3. Top Ten Biotechnology Drugs by U.S. Sales in 2003

Table 4. Top Drug/Medical Companies in R&D in 2003 (Ranked by R&D Expenditures)

Table 5. FDA Authorizations from the Top 20 Pharmaceutical Companies in 2003

Table 6. Top U.S. Drug Companies by Sales per Advertising Dollar, 2003

Table 7. Top Biotechnology/Pharmaceutical Companies in the U.S. Patenting Activity, 2003

Table 8. The Most Admired U.S. Pharmaceutical Companies in 2003